Pricing Log in Create free account

Bio-Path Holdings, Inc. (BPTH) vs Lunai Bioworks Inc. (LNAI)

Bio-Path Holdings, Inc. and Lunai Bioworks Inc. are both Biotechnology companies. Bio-Path Holdings, Inc. is the larger, with a market value of $1.1M against $830.0K — 1.3× the size. Bio-Path Holdings, Inc. has the higher net margin (0.00% vs −3,761.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Bio-Path Holdings, Inc. leads on 8 and Lunai Bioworks Inc. on 3.

Valuation

Metric BPTH LNAI Biotechnology median
P/E n/m n/m 10.60
P/S n/m 5.68 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.00 n/m 0.66
EV/Sales n/m 0.25 9.02
Earnings yield 0.00% (640.81%) (32.88%)
Free cash flow yield 0.00% (988.00%) (23.13%)

Profitability

Metric BPTH LNAI Biotechnology median
Gross margin 0.00% (3.48%) 68.51%
Operating margin 0.00% (9,184.79%) 0.00%
Net margin 0.00% (3,761.88%) 0.00%
Free cash flow margin 0.00% (5,610.24%) 0.00%
Return on equity 157.01% 23.46% (51.96%)
Return on assets (605.50%) (39.21%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BPTH LNAI Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 87.75% 98.77% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BPTH LNAI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.07 0.11 4.97
Net debt to EBITDA 0.10 0.20 1.01

Dividend

Metric BPTH LNAI Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BPTH LNAI Biotechnology median
Market cap 1.07m 830.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack